Haruhiko Kondo
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Diagnosis and Treatment 68
- Lung Cancer Treatments and Mutations 40
- Medical Imaging and Pathology Studies 26
- Tracheal and airway disorders 20
- Pleural and Pulmonary Diseases 18
- Oncology top 1%
- Lung Cancer Research Studies 20
- Cancer Diagnosis and Treatment 13
- Microbiology top 2%
- Hepatology top 2%
- Neurology top 2%
- Myasthenia Gravis and Thymoma 13
- Co-authors
- Ryosuke TsuchiyaHisao AsamuraTsuguo NarukeHaruhiko NakayamaKenji SuzukiKeiichi SuemasuTomoyuki GoyaTakehiro Okumura
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Haruhiko Kondo
189 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 111
- Pulmonary and Respiratory Medicine 4.2k
- Oncology 2.2k
- Microbiology 57
- Hepatology 404
- Neurology 546
Countries citing papers authored by Haruhiko Kondo
This map shows the geographic impact of Haruhiko Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhiko Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhiko Kondo more than expected).
Fields of papers citing papers by Haruhiko Kondo
This network shows the impact of papers produced by Haruhiko Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhiko Kondo. The network helps show where Haruhiko Kondo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haruhiko Kondo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 2 | |
| 7 | 2019 | 23 | |
| 8 | The Safety of Pegylated Liposomal Doxorubicin Plus Irinotecan in Recurrent Ovarian Cancer Patients: A Phase I Trial. | 2015 | 5 |
| 9 | 2014 | 64 | |
| 10 | 2014 | 107 | |
| 11 | 2012 | 5 | |
| 12 | 2011 | 6 | |
| 13 | 2009 | 0 | |
| 14 | 2003 | 24 | |
| 15 | 1997 | 16 | |
| 16 | TIME TRENDS AND SURVIVAL RATE OF LUNG CANCER | 1995 | 5 |
| 17 | 1993 | 86 | |
| 18 | 1990 | 1 | |
| 19 | 1989 | 20 | |
| 20 | Evaluation on significance of neck ultrasound examination in primary lung cancer : Detection of non-palpable metastatic scalene nodes | 1988 | 1 |
About Haruhiko Kondo
Haruhiko Kondo is a scholar working on Pulmonary and Respiratory Medicine, Microbiology and Oncology, having authored 205 papers that have together received 6.5k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (68 papers), Lung Cancer Treatments and Mutations (40 papers), Medical Imaging and Pathology Studies (26 papers), Tracheal and airway disorders (20 papers), Lung Cancer Research Studies (20 papers), Pleural and Pulmonary Diseases (18 papers), Myasthenia Gravis and Thymoma (13 papers) and Cancer Diagnosis and Treatment (13 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.2k citations), Oncology (2.2k citations) and Microbiology (57 citations). Haruhiko Kondo has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Ryosuke Tsuchiya, Hisao Asamura, Tsuguo Naruke, Haruhiko Nakayama, Kenji Suzuki, Keiichi Suemasu, Tomoyuki Goya, Takehiro Okumura, Yoshihiro Matsuno and Yasuhisa Ohde. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.